Author : Zafar, Mehreen


Italy, China and Turkey are the Top Three Countries in Health Research Publications for the Year 2019-2020: Analysis of One Hundred and Forty Countries (140)

Waseem Hassan; Mehreen Zafar

Canadian Journal of Medicine, 2021, Volume 3, Issue 1, Pages 1-5
DOI: 10.33844/cjm.2021.60497

The SARS-CoV-2 virus has significantly affected every aspect of life such as health, economy, and socio-economic fabric, and research activities. This motivated us to explore the research output of more than 145 countries in health sciences research for 2019-2020. It is noteworthy that research outputs are classified in “health sciences”, health professions, dentistry, medicine, multidisciplinary, nursing and veterinary. Scopus (Elsevier BV Company, USA) was employed for the purpose. The data were independently screened, sorted, and extracted on 26th Dec, 2020. Based on the number of publications and research growth rate, we designed the publication clubs and provided the ranking details in Table 1. if we keep the number of publications to be ten thousand (10,000), it was found that Italy has the highest growth rate (n = 29.92), followed by China (n = 28.27) and Turkey (n=25.36). Regardless of the minimum number of publications, Uzbekistan has the highest growth rate (n = 124.69), followed by Democratic Republic Congo (DRC) (n = 93.55) and Jamaica (n = 68.93). The numerical details about the research progress of more than 140 countries are provided in Table 2. It can be concluded that significant progress can be noticed in health sciences during the COVID-19 pandemic.

Pharmacology, Toxicology, and Pharmaceutics Research Output in One Hundred and Fifty Countries for the Year 2019-2020

Waseem Hassan; Mehreen Zafar

Canadian Journal of Medicine, 2021, Volume 3, Issue 1, Pages 56-60
DOI: 10.33844/cjm.2021.60503

In this note, the data about “Pharmacology, Toxicology, and Pharmaceutics” is compiled.
Scopus has included pharmacology, toxicology & pharmaceutics (all), pharmacology,
toxicology, pharmaceutics (miscellaneous), drug discovery, pharmaceutical science,
pharmacology, and toxicology in the stated category. We analyzed the publications data of
one hundred and fifty (150) countries for 2019-2020. The data were independently screened,
sorted, and extracted on 29
th Dec 2020 (from Scopus). Based on the number of publications
(NoP) and growth rate (GR), we designed and ranked the top country in each “publication
club,” as shown in Table 1. Furthermore, if we ignore the minimum number of publications,
the top ten ranked countries with growth rate are Uzbekistan (n = 1388.37), Ethiopia (n =
238.64), Brunei Darussalam (n = 200.00), Gambia (n = 200.00), Mongolia (n = 171.43),
Honduras (n = 150.00), Philippines (n = 144.00), Rwanda (n = 142.86), French Polynesia (n
= 125.00) and Benin (n = 120.00). Based on the total publication record from more than 150
countries (n = 118706 for 2020 and n = 100366 for 2019), a significant and positive growth
rate (n = 18.27) has been noticed in “Pharmacology, Toxicology, and Pharmaceutics”. The
NoP and GR details of each country are provided in Table 2